1303109009: Product containing ertugliflozin and sitagliptin in oral dose form (medicinal product form)

SNOMED CT Concept\Pharmaceutical / biologic product\Medicinal product (product)\...

\Medicinal product categorized by disposition (product)\Sodium glucose cotransporter subtype 2 inhibitor-containing product\Product containing ertugliflozin (medicinal product)\Ertugliflozin- and sitagliptin-containing product\Ertugliflozin- and sitagliptin-containing product in oral dose form
\Medicinal product categorized by disposition (product)\Sodium glucose cotransporter subtype 2 inhibitor-containing product\Product containing ertugliflozin (medicinal product)\Product containing ertugliflozin in oral dose form (medicinal product form)\Ertugliflozin- and sitagliptin-containing product in oral dose form
\Medicinal product categorized by disposition (product)\Product containing enzyme inhibitor (product)\Hydrolase inhibitor-containing product\Product containing peptide hydrolase inhibitor (product)\Product containing proteinase inhibitor (product)\Serine proteinase inhibitor-containing product\Product containing sitagliptin (medicinal product)\Ertugliflozin- and sitagliptin-containing product\Ertugliflozin- and sitagliptin-containing product in oral dose form
\Medicinal product categorized by disposition (product)\Product containing enzyme inhibitor (product)\Hydrolase inhibitor-containing product\Product containing peptide hydrolase inhibitor (product)\Product containing proteinase inhibitor (product)\Serine proteinase inhibitor-containing product\Product containing sitagliptin (medicinal product)\Product containing sitagliptin in oral dose form (medicinal product form)\Ertugliflozin- and sitagliptin-containing product in oral dose form
\Medicinal product categorized by disposition (product)\Product containing enzyme inhibitor (product)\Hydrolase inhibitor-containing product\Product containing peptide hydrolase inhibitor (product)\Product containing dipeptidyl peptidase IV inhibitor (product)\Product containing sitagliptin (medicinal product)\Ertugliflozin- and sitagliptin-containing product\Ertugliflozin- and sitagliptin-containing product in oral dose form
\Medicinal product categorized by disposition (product)\Product containing enzyme inhibitor (product)\Hydrolase inhibitor-containing product\Product containing peptide hydrolase inhibitor (product)\Product containing dipeptidyl peptidase IV inhibitor (product)\Product containing sitagliptin (medicinal product)\Product containing sitagliptin in oral dose form (medicinal product form)\Ertugliflozin- and sitagliptin-containing product in oral dose form

\Medicinal product categorized by structure (product)\Nitrogen and/or nitrogen compound-containing product\Azole-containing product\Product containing sitagliptin (medicinal product)\Ertugliflozin- and sitagliptin-containing product\Ertugliflozin- and sitagliptin-containing product in oral dose form
\Medicinal product categorized by structure (product)\Nitrogen and/or nitrogen compound-containing product\Azole-containing product\Product containing sitagliptin (medicinal product)\Product containing sitagliptin in oral dose form (medicinal product form)\Ertugliflozin- and sitagliptin-containing product in oral dose form
\Medicinal product categorized by structure (product)\Product containing ertugliflozin (medicinal product)\Ertugliflozin- and sitagliptin-containing product\Ertugliflozin- and sitagliptin-containing product in oral dose form
\Medicinal product categorized by structure (product)\Product containing ertugliflozin (medicinal product)\Product containing ertugliflozin in oral dose form (medicinal product form)\Ertugliflozin- and sitagliptin-containing product in oral dose form

\Product manufactured as oral dose form (product)\Product containing sitagliptin in oral dose form (medicinal product form)\Ertugliflozin- and sitagliptin-containing product in oral dose form
\Product manufactured as oral dose form (product)\Product containing ertugliflozin in oral dose form (medicinal product form)\Ertugliflozin- and sitagliptin-containing product in oral dose form

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Feb 2024. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

5304784015 Ertugliflozin- and sitagliptin-containing product in oral dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

5304785019 Product containing ertugliflozin and sitagliptin in oral dose form (medicinal product form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

5304784015 Ertugliflozin- and sitagliptin-containing product in oral dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

5304785019 Product containing ertugliflozin and sitagliptin in oral dose form (medicinal product form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Ertugliflozin- and sitagliptin-containing product in oral dose form	Is a	Ertugliflozin- and sitagliptin-containing product	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Ertugliflozin- and sitagliptin-containing product in oral dose form	Is a	Product containing ertugliflozin in oral dose form (medicinal product form)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Ertugliflozin- and sitagliptin-containing product in oral dose form	Is a	Product containing sitagliptin in oral dose form (medicinal product form)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Ertugliflozin- and sitagliptin-containing product in oral dose form	Has manufactured dose form	Oral dose form	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Ertugliflozin- and sitagliptin-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Sitagliptin (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Ertugliflozin- and sitagliptin-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Ertugliflozin	true	Inferred relationship	Existential restriction modifier (core metadata concept)	2

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing only ertugliflozin and sitagliptin in oral dose form (medicinal product form)	Is a	True	Ertugliflozin- and sitagliptin-containing product in oral dose form	Inferred relationship	Existential restriction modifier (core metadata concept)

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
5304784015	Ertugliflozin- and sitagliptin-containing product in oral dose form	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
5304785019	Product containing ertugliflozin and sitagliptin in oral dose form (medicinal product form)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
5304784015	Ertugliflozin- and sitagliptin-containing product in oral dose form	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
5304785019	Product containing ertugliflozin and sitagliptin in oral dose form (medicinal product form)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core